Share Email Print

Proceedings Paper

Nd:YAG laser treatment in patients with prostatic adenocarcinoma stage A
Author(s): Franco Gaboardi; Ernesto Dotti; Andrea Bozzola; Luigi Galli
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

This paper describes laser irradiation in the prostatic adenocarcinoma of stage A. Prostatic adenocarcinoma is an unsuspected prostatic tumor, incidentally discovered during an hystologic examination after TURP or adenectomy, limited to the prostate. Sixteen patients with hystological diagnosis of prostatic carcinoma of stage A (12 A1 and 4 A2) entered the trial. After ultrasound control of the reduced prostatic tissue to a thin residual capsule an endoscopic and percutaneous irradiation with endoscopic Nd:YAG laser was performed. Average follow-up is 18 months (range 6-48). All patients had negative biopsies. No tumor had progressed. There were no side effects, both potency and continence were unchanged. The results are promising and comparable to short-term results obtained with conventional treatment.

Paper Details

Date Published: 1 July 1991
PDF: 6 pages
Proc. SPIE 1421, Lasers in Urology, Laparoscopy, and General Surgery, (1 July 1991); doi: 10.1117/12.43907
Show Author Affiliations
Franco Gaboardi, Fatebenefratelli Hospital (Italy)
Ernesto Dotti, Fatebenefratelli Hospital (Italy)
Andrea Bozzola, Fatebenefratelli Hospital (Italy)
Luigi Galli, Fatebenefratelli Hospital (Italy)

Published in SPIE Proceedings Vol. 1421:
Lasers in Urology, Laparoscopy, and General Surgery
Graham M. Watson; Rudolf W. Steiner; Joseph J. Pietrafitta, Editor(s)

© SPIE. Terms of Use
Back to Top